Earkart Limited IPO Review, Date, Price, Allotment Details

The Earkart Limited is scheduled to open for subscription on September 25, 2025, and will close on September 29, 2025. The allotment will be finalized on September 30, 2025, and the shares are expected to list on the BSE and SME on October 3, 2025. This SME IPO is attracting investors due to the company’s strong financial growth and an attractive price band of ₹135 Per Share.

Here’s a complete guide covering IPO details, dates, promoters, financials, strengths, risks, and how to apply.

Earkart Limited IPO Details

ParticularsDetails
IPO Open Date25/09/2025
IPO Close Date29/09/2025
Face Value₹10 Per Equity Share
IPO Price Band₹135 Per Share
Issue SizeApprox ₹49.26Crores
Fresh IssueApprox ₹44.75 Crores
Offer for SaleApprox 3,34,000 Equity Shares
Issue TypeFixed Price Issue
IPO ListingBSE, SME
RHP Draft ProspectusDownload
DRHP Draft ProspectusDownload

Bhavik Enterprises IPO Date, Price, Review, Allotment Details

Earkart Limited IPO Market Lot

The minimum market lot for Earkart Limited IPO is 2000 shares, with a total application amount of ₹2,70,000.

ApplicationLot SizeSharesAmount
Retail Minimum22,000₹2,70,000
Retail Maximum22,000₹2,70,000
S-HNI Minimum33,000₹4,05,000

Earkart Limited IPO Reservation

Investor CategoryShare Offered% Shares
Market Maker Shares Offered1,85,000 Shares5.07%
NII Shares Offered17,32,000 Shares47.47%
Retail Shares Offered17,32,000 Shares47.47%

Earkart Limited IPO Timeline

The Earkart Limited opens on September 25, 2025, and closes on September 29, 2025. The allotment will be finalized on September 30, 2025, with the shares list on October 3, 2025.

EventDate
IPO Open DateSeptember 25, 2025
IPO Close DateSeptember 29, 2025
Basis of AllotmentSeptember 30, 2025
Refunds InitiationOctober 1, 2025
Credit to Demat AccountOctober 1, 2025
IPO Listing DateOctober 3, 2025
IPO Bidding Cut-off TimeSeptember 29, 2025 – 5:00 PM

Promaters and Holding Pattern

The promoters of Earkart Limited are Rohit Misra and Monika Misra. who is responsible for guiding the company’s strategic growth and operational decisions.

ParticularShares% Share
Promoter Holding Pre Issue1,04,38,93278.75%
Promoter Holding Post Issue1,37,53,93257.34%

Objects of the Issue & Utilisation of proceeds

PurposeCrores
Funding incremental working capital requirements of our Company21.10
Funding capital expenditure requirements for setting of Shop in Shop (SIS) Business Model in ENT/Ophthalmic Clinics across India and Setting up of Infrastructure for operational activities17.33
General Corporate Purpose

Company Financial

Amount ₹ in Crores

Period EndedMarch-2025March-2024March-2023
Assets30.2919.2514.73
Revenue43.1931.9728.97
Net Worth19.9213.036.56
profit After Tax6.883.061.31
Reserves And Surpluse9.4812.976.49
Total Borrowing4.9641.21

Earkart Limited IPO Valuation

Check Earkart Limited IPO valuation details, including Price/Earnings P/E Ratio, Earnings Per Share (EPS), Return on Net Worth (RoNW), and Net Asset Value (NAV).

KPIMarch-2025March-2024March-2023
EPS6.592.030.87
ROE34.5523.4619.99
ROCE47.3227.4423.00
RONW00
PRE IPO(PE)20.4800
POST IPO(PE)26.9800

Rukmani Devi IPO Details, Dates, Price, and Company Insights

About company

Earkart is a hearing healthcare solutions company that makes hearing aids and other assistive devices under brands like EQFY, Fame, and Radius. It also distributes accessories such as foldable walkers and educational material for physically challenged people.

The firm operates through multiple channels including government supplies (via GeM and ALIMCO), online sales, and a Shop-in-Shop (SIS) model inside ENT/optical clinics. As of 2024, it has about 49 SIS clinics across 22 cities in six states and two union territories


Earkart Limited IPO Strength Factors

  1. Growing sector: Demand for hearing aids and assistive devices is increasing, especially in Tier 2 & 3 cities.
  2. Multi-channel presence: Government supply, store-in-store (SIS), clinics, online—helps reach more customers.
  3. Innovative models: Shop‐in‐Shop network in ENT/optical clinics enhances distribution.
  4. Good financial growth: Revenue and profit increasing, showing operational efficiency.
  5. Affordable pricing: Fixed price IPO, product range targeted to be affordable.

Earkart Limited IPO Risk Factors

  1. High minimum investment: Lot of 1,000 shares at ₹135 means a relatively high ticket size for small retail investors.
  2. Competition: Hearing healthcare tech is competitive; maintaining product innovation is vital.
  3. Dependence on government contracts: Supply through GeM and ALIMCO involves regulatory risk and tender dynamics.
  4. Execution & scaling risk: Expanding Shop-in-Shop network, production, and infrastructure may face challenges.
  5. Grey market premium low: GMP shows muted expectations, could indicate modest listing gains.

Lead Manager

  • Sarthi Capital Advisors Pvt.Ltd.

Company Details

  • Name:- Earkart Limited
  • Email:- cs@earkart.in
  • Phone:- 0120-4102857
  • Website:- https://www.earkart.in/
  • Address:- Shop No. 8-P, Street No. 6, Vasundhara Enclave, East Delhi, New Delhi, 110096

IPO Registrar


Disclemer

IPO Sevak (iposevak.com) is not a SEBI-registered advisor. This content is for informational purposes only and should not be considered as investment advice. Please consult a licensed financial advisor before investing.


FAQs

1. When does the Earkart Limited IPO open and close?

Ans:- The IPO opens on September 25, 2025, and closes on September 29, 2025.

2. What is the price band for the Earkart Limited IPO?

Ans:- The price band is ₹135 Per Share.

3. What is the minimum lot size and investment amount?

Ans:- The minimum market lot is 2000 shares, requiring an investment of ₹2,70,000.

4. Who are the promoters of the Earkart Limited?

Ans:- The promoters are Rohit Misra and Monika Misra.

5. When will the allotment be finalized?

Ans:- The allotment will be finalized on September 30, 2025.

6. When will the Earkart Limited IPO list on the stock exchange?

Ans:- The shares are expected to list on the BSE, SME on October 3, 2025.

Leave a Comment